Open access · US-GOV via ClinicalTrials.gov Clinical trial

Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients Undergoing Surgery and Chemotherapy

Authors not listed

Population Health Research Institute · 2023

Dysbiosis Human Randomized controlled trial Cohort study

Abstract

FARGO is a prospective cohort study that aims to determine the performance of preoperative frailty assessment based on the Frailty Phenotype (FP), compared to a perioperative cardiovascular risk assessment based on the combination of preoperative Revised Cardiac Risk Index (RCRI), age and occurrence of myocardial injury after noncardiac surgery (MINS), in predicting the composite of all-cause death or new disability at 6 months after surgery in patients aged 55 or older. Patients will have confirmed or suspected gynecologic cancer, undergoing cytoreductive or high-risk surgery with or without chemotherapy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-14 MST

Cite this

APA

Anonymous. (2023). Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients Undergoing Surgery and Chemotherapy. <em>Population Health Research Institute</em>. https://clinicaltrials.gov/study/NCT05738252

Vancouver

Anonymous. Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients Undergoing Surgery and Chemotherapy. Population Health Research Institute. 2023.

BibTeX

@misc{anon2023Frailt, title = {Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients Undergoing Surgery and Chemotherapy}, author = {Anonymous}, journal = {Population Health Research Institute}, year = {2023}, }